(A)KLF5 expression in AML patients with high or low methylation and A/A or G/A SNP genotype, (B) Kaplan Meier overall survival curves of patients with high versus low KLF5 methylation, median survival in months (mo) is indicated as well as percentage survival at 5 years (C) Kaplan Meier overall survival curves of AML patients stratified by both KLF5 methylation and SNP genotype. P values represent analysis of the comparison of the High+G/A group to the other 3 groups.